» Articles » PMID: 29684818

GLUT1 Protects Prostate Cancer Cells from Glucose Deprivation-induced Oxidative Stress

Overview
Journal Redox Biol
Date 2018 Apr 24
PMID 29684818
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose, chief metabolic support for cancer cell survival and growth, is mainly imported into cells by facilitated glucose transporters (GLUTs). The increase in glucose uptake along with tumor progression is due to an increment of facilitative glucose transporters as GLUT1. GLUT1 prevents cell death of cancer cells caused by growth factors deprivation, but there is scarce information about its role on the damage caused by glucose deprivation, which usually occurs within the core of a growing tumor. In prostate cancer (PCa), GLUT1 is found in the most aggressive tumors, and it is regulated by androgens. To study the response of androgen-sensitive and insensitive PCa cells to glucose deprivation and the role of GLUT1 on survival mechanisms, androgen-sensitive LNCaP and castration-resistant LNCaP-R cells were employed. Results demonstrated that glucose deprivation induced a necrotic type of cell death which is prevented by antioxidants. Androgen-sensitive cells show a higher resistance to cell death triggered by glucose deprivation than castration-resistant cells. Glucose removal causes an increment of HO, an activation of androgen receptor (AR) and a stimulation of AMP-activated protein kinase activity. In addition, glucose removal increases GLUT1 production in androgen sensitive PCa cells. GLUT1 ectopic overexpression makes PCa cells more resistant to glucose deprivation and oxidative stress-induced cell death. Under glucose deprivation, GLUT1 overexpressing PCa cells sustains mitochondrial SOD2 activity, compromised after glucose removal, and significantly increases reduced glutathione (GSH). In conclusion, androgen-sensitive PCa cells are more resistant to glucose deprivation-induced cell death by a GLUT1 upregulation through an enhancement of reduced glutathione levels.

Citing Articles

Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment.

De-Leon-Covarrubias U, Perez-Trujillo J, Villa-Cedillo S, Martinez-Perez A, Montes-de-Oca-Saucedo C, Loera-Arias M Metabolites. 2024; 14(8).

PMID: 39195514 PMC: 11356153. DOI: 10.3390/metabo14080418.


Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer.

Song Q, Zheng Y, Zhong G, Wang S, He C, Li M Anticancer Agents Med Chem. 2024; 24(18):1305-1326.

PMID: 39129164 PMC: 11497148. DOI: 10.2174/0118715206323900240807110122.


mA demethylation of FOSL1 mRNA protects hepatoma cells against necrosis under glucose deprivation.

Wang C, Gong J, Zhao Z, Zhu Q, Shu B, Hu J Cell Death Differ. 2024; 31(8):1029-1043.

PMID: 38762597 PMC: 11303728. DOI: 10.1038/s41418-024-01308-3.


Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis.

Xie Z, Zhou Q, Qiu C, Zhu D, Li K, Huang H Cancer Pathog Ther. 2024; 1(2):127-140.

PMID: 38328400 PMC: 10846326. DOI: 10.1016/j.cpt.2022.10.002.


Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.

Ambrosini G, Cordani M, Zarrabi A, Alcon-Rodriguez S, Sainz R, Velasco G Cell Commun Signal. 2024; 22(1):36.

PMID: 38216942 PMC: 10790277. DOI: 10.1186/s12964-023-01462-0.


References
1.
Andrisse S, Koehler R, Chen J, Patel G, Vallurupalli V, Ratliff B . Role of GLUT1 in regulation of reactive oxygen species. Redox Biol. 2014; 2:764-71. PMC: 4116627. DOI: 10.1016/j.redox.2014.03.004. View

2.
Zmijewski J, Banerjee S, Bae H, Friggeri A, Lazarowski E, Abraham E . Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem. 2010; 285(43):33154-33164. PMC: 2963401. DOI: 10.1074/jbc.M110.143685. View

3.
Massie C, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L . The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J. 2011; 30(13):2719-33. PMC: 3155295. DOI: 10.1038/emboj.2011.158. View

4.
Isono T, Chano T, Yonese J, Yuasa T . Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas. Sci Rep. 2016; 6:25669. PMC: 4860706. DOI: 10.1038/srep25669. View

5.
Yun J, Mullarky E, Lu C, Bosch K, Kavalier A, Rivera K . Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015; 350(6266):1391-6. PMC: 4778961. DOI: 10.1126/science.aaa5004. View